GenFlat Holdings, Inc. entered into Underwriting Agreement with Craig-Hallum Capital Group LLC valued at total gross proceeds of approximately $7.0 million (effective 2026-02-02).
“On February 2, 2026, GenFlat Holdings, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Craig-Hallum Capital Group LLC, in its capacity as underwriter (the “ Underwriter ”), relating to the Company’s public offering (the “ Offering ”) of shares of common stock, par value $0.001 per share (the “ Common Stock ”) pursuant to the Company’s registration statement on Form S-1 (File No. 333 - 291718) (the “ Registration Statement ”), under the Securities Act of 1933, as amended (the “ Securities Act ”).”
Governance Changes
GenFlat Holdings, Inc.: Adopted a new Code of Ethics and Business Conduct applicable to all directors, officers and employees (effective 2025-09-24).
“On September 24, 2025 and effective as of such date, the Board of Directors adopted a new Code of Ethics and Business Conduct (the “ Code ”) applicable to all directors, officers and employees of the Company.”
Garrett R. Hall was appointed as President at GenFlat Holdings, Inc..
“and (ii) accepted the resignation of Garrett R. Hall as the Company’s and GenFlat, Inc.’s Chief Operating Officer and appointed Mr. Hall as the Company’s and GenFlat, Inc.’s President.”
Joseph J. Maggio was appointed as Chief Operating Officer at GenFlat Holdings, Inc..
“On November 27, 2024, Drew D. Hall, the sole member of GenFlat Holdings, Inc.’s (the “ Company ” or GenFlat Holdings ”) Board of Directors (i) accepted the resignation of Joseph J. Maggio as the Company’s and GenFlat, Inc.’s President and appointed Mr. Maggio as the Company’s and GenFlat, Inc.’s Chief Operating Officer;”
Governance Changes
GenFlat Holdings, Inc.: Fiscal year end changed to June 30 as a result of reverse acquisition accounting treatment (effective 2024-02-02).
“In accordance with “reverse acquisition” accounting treatment, the historical financial statements of GenFlat as of period ends, and for periods ended, prior to the acquisition will become the historical financial statements of the Company in all future filings with the SEC, and our fiscal year end is now June 30.”
M&A Transactions
GenFlat Holdings, Inc. underwent a change of control (closed 2023-12-20).
“Additionally, at the closing, a change in control of the Company occurred whereby the existing members of the Company’s executive management and board of directors resigned, and Genflat’s designees were appointed as members of the Company’s executive management and board of directors.”
M&A Transactions
GenFlat Holdings, Inc. completed an acquisition involving GenFlat stockholders (closed 2023-12-20).
“The Share Exchange Agreement closed on December 20, 2023. Pursuant to the Share Exchange Agreement, and on the terms and subject to the conditions contained therein, at the closing, the Company acquired 97.22% of the outstanding shares of common stock of GenFlat from GenFlat stockholders who were a party to the Share Exchange Agreement in exchange for 1,043,847,000 shares of common stock of the Company.”
Material Agreements
GenFlat Holdings, Inc. entered into Share Exchange Agreement with GenFlat, Inc. and GenFlat shareholders who own 97.1% of the outstanding shares of common stock of GenFlat (effective 2023-10-18).
“on October 18, 2023, Healthcare Business Resources Inc. (the “ Company ”) entered into a Share Exchange Agreement (“ Share Exchange Agreemen t”) with GenFlat, Inc. (“ GenFlat ”), a Delaware corporation, and GenFlat shareholders who own 97.1% of the outstanding shares of common stock of GenFlat.”
Garrett R. Hall was appointed as Chief Operations Officer at GenFlat Holdings, Inc..
“Garrett R. Hall Chief Operations Officer”
Joseph J. Maggio was appointed as President at GenFlat Holdings, Inc..
“Joseph J. Maggio President”
Drew D. Hall was appointed as Chief Executive Officer, Chief Financial Officer, Director at GenFlat Holdings, Inc..
“Drew D. Hall was elected to the Board of Directors as the sole director of the Company.”
Howard Wall, III resigned as Director at GenFlat Holdings, Inc..
“On December 20, 2023 (i) each of Stephen Epstein, the sole officer and a director of the Company, and Howard Wall, III, a director of the Company, resigned;”
Stephen Epstein resigned as Sole Officer and Director at GenFlat Holdings, Inc..
“On December 20, 2023 (i) each of Stephen Epstein, the sole officer and a director of the Company, and Howard Wall, III, a director of the Company, resigned;”
Auditor Changes
GenFlat Holdings, Inc. engaged M&K CPAS, PLLC as its auditor.
“On January 29, 2024, the Company appointed M&K CPAS, PLLC ("M&K") as its new independent registered public accounting firm commencing for its quarter ending December 31, 2023, and its fiscal year ending June 30, 2024.”
Auditor Changes
GenFlat Holdings, Inc. dismissed B F Borgers CPA PC as its auditor.
“On January 29, 2024, Healthcare Business Resources Inc. (the "Company") dismissed B F Borgers CPA PC ("BF Borgers") as its independent registered public accounting firm.”
M&A Transactions
GenFlat Holdings, Inc. completed an acquisition involving GenFlat, Inc. for 1,043,847,000 shares of common stock of the Company in exchange for 97.22% of the outstanding shares of GenFlat common stock, plus GenFlat paid $77,500 in Compa (closed 2023-12-20).
“The Share Exchange Agreement closed on December 20, 2023. Pursuant to the Share Exchange Agreement, and on the terms and subject to the conditions contained therein, at the closing, the Company acquired 97.22% of the outstanding shares of common stock of GenFlat from GenFlat stockholders who were a party to the Share Exchange Agreement in exchange for 1,043,847,000 shares of common stock of the Company. Additionally, 11,000,000 shares of outstanding Company common stock were canceled, resulting in 1,054,150,000 shares of common stock issued and outstanding as of the Closing Date. Also, Genflat paid $77,500 in Company payables and paid the Company's outstanding balance due on its senior secured convertible credit line.”
Material Agreements
GenFlat Holdings, Inc. entered into Share Exchange Agreement with GenFlat, Inc. valued at 98% of outstanding shares (effective 2023-12-20).
“As previously reported, on October 18, 2023, Healthcare Business Resources Inc. (the “ Company ”) entered into a Share Exchange Agreement (“ Share Exchange Agreemen t”) with GenFlat, Inc . (“ GenFlat ”), a Delaware corporation, and GenFlat shareholders who own 97.1% of the outstanding shares of common stock of GenFlat.”
Garrett R. Hall was appointed as Chief Operations Officer at GenFlat Holdings, Inc..
“Garrett R. Hall Chief Operations Officer”
Joseph J. Maggio was appointed as President at GenFlat Holdings, Inc..
“Joseph J. Maggio President”
Drew D. Hall was appointed as Chief Executive Officer, Chief Financial Officer at GenFlat Holdings, Inc..
“Drew D. Hall Chief Executive Officer, Chief Financial Officer”
Drew D. Hall was elected as Director at GenFlat Holdings, Inc..
“Drew D. Hall was elected to the Board of Directors as the sole director of the Company.”
Howard Wall, III resigned as Director at GenFlat Holdings, Inc..
“each of Stephen Epstein, the sole officer and a director of the Company, and Howard Wall, III, a director of the Company, resigned”
Stephen Epstein resigned as Sole Officer at GenFlat Holdings, Inc..
“each of Stephen Epstein, the sole officer and a director of the Company, and Howard Wall, III, a director of the Company, resigned”
Stephen Epstein resigned as Director at GenFlat Holdings, Inc..
“each of Stephen Epstein, the sole officer and a director of the Company, and Howard Wall, III, a director of the Company, resigned”
Governance Changes
GenFlat Holdings, Inc.: Increased authorized common stock from 200M to 2.5B shares (effective 2023-10-16).
“On September 8, 2023, the stockholders of Healthcare Business Resources Inc. (the “Company”) approved an amendment (the “Amendment”) to the Company’s Certificate of Incorporation to increase the total number of shares of common stock that the Company shall have authority to issue from 200,000,000 shares to 2,500,000,000 shares. The Amendment was filed with the Secretary of the State of Delaware and became effective on October 16, 2023.”
Kenneth D. Hawkins resigned as Director at GenFlat Holdings, Inc..
“On July 18, 2022, Kenneth D. Hawkins tendered his resignation as a director of Healthcare Business Resources Inc. (the “ Company ”) to the Company effective immediately. The departure of Mr. Hawkins from his position as a member of the Company’s Board of Directors was for personal reasons.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.